Harvard Bioscience, Inc. (HBIO)

Harvard Bioscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Nov 21, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Market Capitalization	94	228	115	288	167	116
Market Cap Growth	-36.09%	97.92%	-59.89%	72.07%	44.02%	-2.10%
Enterprise Value	136	268	167	336	218	175
Last Close Price	2.16	5.35	2.77	7.05	4.29	3.05
Forward PE	24.00	23.26	17.87	22.03	16.19	16.58
PS Ratio	0.96	2.03	1.02	2.42	1.64	1.00
PB Ratio	1.44	3.13	1.60	3.45	2.18	1.42
P/FCF Ratio	109.93	18.66	-	4294.24	20.44	17.00
P/OCF Ratio	23.12	16.28	100.17	227.98	17.92	14.43
PEG Ratio	1.03	1.03	1.03	1.03	1.03	1.03
EV/Sales Ratio	1.39	2.39	1.47	2.83	2.14	1.51
EV/EBITDA Ratio	47.03	28.27	70.15	29.72	22.08	17.85
EV/EBIT Ratio	-	107.55	-	91.12	96.86	84.46
EV/FCF Ratio	160.41	21.92	-	5018.20	26.69	25.63
Debt / Equity Ratio	0.70	0.59	0.75	0.68	0.75	0.80
Debt / EBITDA Ratio	9.15	3.69	12.09	4.24	4.79	5.56
Debt / FCF Ratio	54.34	3.49	-	850.15	7.04	9.53
Asset Turnover	0.72	0.79	0.74	0.75	0.64	0.70
Inventory Turnover	1.56	1.79	1.89	2.06	1.99	2.19
Quick Ratio	0.76	0.77	0.91	1.17	1.24	1.15
Current Ratio	2.06	1.85	2.20	2.43	2.46	2.12
Return on Equity (ROE)	-20.40%	-4.70%	-12.23%	-0.36%	-9.86%	-5.70%
Return on Assets (ROA)	-1.98%	1.10%	-2.11%	1.45%	0.88%	0.78%
Return on Capital (ROIC)	-2.32%	1.29%	-2.43%	1.68%	1.00%	0.89%
Earnings Yield	-15.33%	-1.50%	-8.25%	-0.10%	-4.67%	-4.04%
FCF Yield	0.91%	5.36%	-0.38%	0.02%	4.89%	5.88%
Buyback Yield / Dilution	-2.68%	-2.43%	-2.65%	-4.41%	-2.19%	-3.73%
Total Shareholder Return	-2.68%	-2.43%	-2.65%	-4.41%	-2.19%	-3.73%

Source: S&P Capital IQ. Standard template. Financial Sources.